{"public_id":"cl_93a5a5fb476530547f34e53a54510c2a","status":"active","superseded_by_public_id":null,"corpus_id":68980952,"text":"A single 1-hour infusion of rhLCAT (ACP-501) in a familial LCAT deficiency patient raised HDL-C from <5 mg/dL to 17 mg/dL at 8 hours, with measurable HDL-C persisting for 7 days.","confidence":0.97,"paper":{"corpus_id":68980952,"title":"Abstract 18673: Human Enzyme Replacement Therapy in a Patient With Familial Lecithin Cholesterol Acyltransferase Deficiency: Rapid Appearance of Normal Appearing HDL","url":"https://sah.borca.ai/papers/68980952"},"contributors":[{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["extraction"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1561cb971a7f863ab9300f424df99782","name":"recombinant human LCAT","description":"An exogenously produced form of the human LCAT enzyme administered as enzyme replacement therapy, designated ACP-501 in this study.","types":["therapeutic agent","biologic"],"url":"https://sah.borca.ai/concepts/co_1561cb971a7f863ab9300f424df99782"},{"public_id":"co_29dc628707132bb76aa44b23d5d9fbb7","name":"familial LCAT deficiency","description":"A rare inherited disorder caused by mutations in the LCAT gene, characterized by absent HDL-C, corneal opacities, anemia, and severe renal disease.","types":["genetic disorder","condition"],"url":"https://sah.borca.ai/concepts/co_29dc628707132bb76aa44b23d5d9fbb7"},{"public_id":"co_e7344f6c8c1c4a42753c02a96834735b","name":"high-density lipoprotein cholesterol","description":"The cholesterol carried by HDL particles, which was absent (<5 mg/dL) at baseline in this FLD patient and monitored as a therapeutic endpoint.","types":["lipoprotein","biomarker"],"url":"https://sah.borca.ai/concepts/co_e7344f6c8c1c4a42753c02a96834735b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_93a5a5fb476530547f34e53a54510c2a"}